To investigate the susceptible factors of liver injury after chemotherapy with R-CHOP (rituximab+cyclophosphamide+doxorubicin hydrochloride liposome injection+oncovin+prednisone) in non-Hodgkin lymphoma (NHL) patients, and to observe the hepatoprotective effect of prophylactic magnesium isocyanate.
The clinical data of 328 NHL patients who met the diagnostic criteria were collected and analyzed from January 1, 2016 to December 31, 2021 in the Department of Hematology, Shidong Hospital, Yangpu District, Shanghai. According to whether hepatoprotective treatment was used in chemotherapy, the patients were divided into two groups according to whether or not hepatoprotective treatment. First, the liver injury patients were determined in the group of unprotected liver patients, and the susceptible factors for liver injury after R-CHOP chemotherapy were analyzed. Then all patients were divided into four groups: non-susceptible factors without liver protection group (A group), susceptible factors without liver protection group (B group), non-susceptible factors with liver protection group (C group), susceptible factor with liver protection group (D group). Groups C and D were treated with magnesium isoglycyrrhizinate for liver protection. The incidence of liver injury and the changes of liver function indexes alanine aminotransferase (ALT), alkaline phosphatase (ALP) and (total bilirubin, TBiL)] of all patients before and after chemotherapy were compared and statistically analyzed.
Alcohol consumption, non-alcoholic fatty liver disease, HBV carriers, and lymphoma liver infiltration were found to be independent susceptible factors for liver injury in NHL patients after R-CHOP chemotherapy. There was no significant difference in the incidence of liver injury (8.13%/5.48%) among the patients without susceptibility factors, while in the patients with susceptibility factors, the incidence of liver injury in the liver protection patients was significantly reduced (7.55%/40.51%). The levels of ALT, ALP and TBiL in patients with susceptibility factors were higher than those without susceptibility factors, and the differences were statistically significant (P<0.05).
Alcohol consumption, non-alcoholic fatty liver disease, HBV carriers and liver infiltration of lymphoma are independent susceptible factors for liver injury in NHL patients after R-CHOP chemotherapy. For NHL patients with the above susceptible factors, magnesium isoglycyrrhizinate can be used to protect the liver effectively during R-CHOP chemotherapy.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |